Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by itntdfon Mar 18, 2024 2:21pm

133 Views

Post# 35938791

maybe oncy can get some closet space and reopen san diego

still looking to see if oncy has inked a deal for san diego office space.

their recent filing said they had a 5.3 year lease liability for well over $1 million for one of their subsidiaries. their filing only indicated two subs, barbados and san diego. keep looking for a san diego lease, but nothing concrete to date.

funny their website encourages reaching out to them but they have no san diego phone.

seems like san diego is the place to be.

https://commercialobserver.com/2024/03/pfizer-signs-san-diegos-largest-life-sciences-deal-of-2024-so-far/

<< Previous

Bullboard Posts

Next >>

Mid-year review: How has gold been performing?